Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2011-05-16
Original SEC Filing: Click here

---

Webplus: BSPM/20110516/8-K/2_EX-99.1/000.htm SEC Original: ex99-1.htm
Biostar Pharmaceuticals, Reports First Quarter 2011 Results; Revenuesrease 24% to $15.3 Million withjusted EPS of $0.11 XIANYANG, China, May 16, 2011 — Biostar Pharmaceuticals, (Nasdaq: BSPM) (“Biostar” or “thempany”), Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acidpsules (“Xin Aoxingpsules”), and a variety of pharmaceutical products, today announced financial results for

---

---

Webplus: BSPM/20110516/8-K/1/000.htm SEC Original: biostarpharma8k051311.htm
FORM 8-K CURRENT REPORT May 16, 2011te of Report (Date of earliest event reported): BIOSTAR PHARMACEUTICALS, Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer oforporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province Peoples Republic of China 712046 86-029-33686638 N/A (Former name or formerdress, if changed since last report)

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2011-05-16CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046